Skip to main content

Menopausal Symptoms

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Bayer
BayerLEVERKUSEN, Germany
1 program
European Active Surveillance Study of Women Taking Hormone Replacement Therapy (HRT)N/A1 trial
Active Trials
NCT00214903Completed30,597Est. Nov 2011

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
BayerEuropean Active Surveillance Study of Women Taking Hormone Replacement Therapy (HRT)

Clinical Trials (1)

Total enrollment: 30,597 patients across 1 trials

NCT00214903BayerEuropean Active Surveillance Study of Women Taking Hormone Replacement Therapy (HRT)

European Active Surveillance Study of Women Taking Hormone Replacement Therapy (HRT)

Start: Nov 2004Est. completion: Nov 201130,597 patients
N/ACompleted

Related Jobs

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.